Alps Advisors Inc Alpine Immune Sciences, Inc. Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.75 - $41.6 $117,700 - $275,849	6,631 Added 16.75%	46,222 $1.83 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $338,107 - $800,530	39,591 New	39,591 $754,000
Q2 2022 Aug 11, 2022	SELL	$6.71 - $9.52 $201,501 - $285,885	-30,030 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.41 - $13.89 $24,261 - $52,573	-3,785 Reduced 11.19%	30,030 $269,000
Q4 2021 Feb 09, 2022	BUY	$10.41 - $13.95 $46,959 - $62,928	4,511 Added 15.39%	33,815 $468,000
Q3 2021 Nov 15, 2021	SELL	$8.19 - $11.31 $17,968 - $24,814	-2,194 Reduced 6.97%	29,304 $313,000
Q2 2021 Aug 11, 2021	BUY	$8.81 - $15.03 $277,497 - $473,414	31,498 New	31,498 $283,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.